Clinical Trials Directory

Trials / Completed

CompletedNCT01785095

Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation Cycles

Prospective, Open-label, Uncontrolled Clinical Trial Evaluating Multiple Controlled Ovarian Hyperstimulation Cycles in Oocyte Donor, to Assess the Immunogenicity of FSH-IBSA

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
41 (actual)
Sponsor
IBSA Institut Biochimique SA · Industry
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to evaluate immunogenic potential of FSH-IBSA in healthy volunteers undergoing controlled ovarian hyperstimulation (COH) in an oocyte donation program.

Conditions

Interventions

TypeNameDescription
DRUGFSH (Follicle Stimulating Hormone)

Timeline

Start date
2013-03-01
Primary completion
2014-07-01
Completion
2014-11-01
First posted
2013-02-07
Last updated
2017-02-09
Results posted
2015-03-27

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01785095. Inclusion in this directory is not an endorsement.

Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation Cycles (NCT01785095) · Clinical Trials Directory